Gemtesa 75 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FA1J1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,907
Award facts
- Contract value 100% obligated
- $43,907.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $43,907.36 to AmerisourceBergen Drug Corp for GEMTESA 75 MG tablets (30-count units) on January 5, 2026, with an ultimate completion date of January 6, 2026. This competitively awarded, firm fixed price delivery order represents a non-set-aside procurement and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. GEMTESA is a prescription medication used to treat overactive bladder symptoms, reflecting the pharmaceutical supply chain support that DLA Medical Supply Chain provides to military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialized medical commodities to support military healthcare programs globally. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard through this flexible contracting mechanism, which positions the company as a critical vendor in the federal medical procurement landscape.
Quick answers
Who was awarded contract SPE2DR26FA1J1?
SPE2DR26FA1J1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FA1J1 worth?
The government has obligated $43,907 on SPE2DR26FA1J1.
Is contract SPE2DR26FA1J1 an order under another contract?
Yes. SPE2DR26FA1J1 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA1J1 competed?
The extent of competition for SPE2DR26FA1J1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award